Connect Biopharma Holdings (CNTB) Leases (2023 - 2025)
Connect Biopharma Holdings' Leases history spans 3 years, with the latest figure at $737000.0 for Q3 2025.
- For Q3 2025, Leases changed N/A year-over-year to $737000.0; the TTM value through Sep 2025 reached $737000.0, changed N/A, while the annual FY2024 figure was $189000.0, 59.09% down from the prior year.
- Leases for Q3 2025 was $737000.0 at Connect Biopharma Holdings, down from $825000.0 in the prior quarter.
- Across five years, Leases topped out at $928000.0 in Q1 2025 and bottomed at $189000.0 in Q4 2024.
- The 3-year median for Leases is $737000.0 (2025), against an average of $628200.0.
- The largest YoY upside for Leases was 59.09% in 2024 against a maximum downside of 59.09% in 2024.
- A 3-year view of Leases shows it stood at $462000.0 in 2023, then crashed by 59.09% to $189000.0 in 2024, then soared by 289.95% to $737000.0 in 2025.
- Per Business Quant, the three most recent readings for CNTB's Leases are $737000.0 (Q3 2025), $825000.0 (Q2 2025), and $928000.0 (Q1 2025).